Status:
NOT_YET_RECRUITING
Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
Lead Sponsor:
Stanford University
Conditions:
Postural Tachycardia Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS)...
Detailed Description
Postural Tachycardia Syndrome (POTS) is a heterogeneous condition affecting approximately 0.2% of the global population, predominantly young women of childbearing age. It is characterized by significa...
Eligibility Criteria
Inclusion
- Adult patients (\>18 years of age) diagnosed with POTS
- Ability to provide informed consent
- Ability to comply with 3 follow up visits
- English speaking and capable of signing informed consent and complying with protocol requirements
Exclusion
- Allergy to local anesthetics
- Severe coagulopathy
- History of or currently being treated for clinically significant ongoing cardiac arrhythmia, heart failure, myocarditis, pulmonary embolism requiring anticoagulation, pulmonary fibrosis or other pulmonary diagnosis that in the investigator's opinion may contribute to symptoms of POTS
- Inability to maintain a stable medication regiment for the duration of the study
Key Trial Info
Start Date :
October 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06953661
Start Date
October 13 2025
End Date
November 1 2026
Last Update
October 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94304
2
Stanford University
Stanford, California, United States, 94305